EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease

Gustavo Basurto-Islas, Maximiliano Caye Diaz, Lizeth M Zavala Ocampo, Melchor Martínez-Herrera, Perla Y López-Camacho

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.202400721 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Gustavo Basurto-Islas und 4 weiteren Autor:innen. Beteiligte Einrichtung: División de Ciencias e Ingenierías, Universidad de Guanajuato, León, Guanajuato, Mexico. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Biological Products, Protein Aggregation, Pathological. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 316 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONAHCYT, Convocatoria Institucional de Investigación Científica 2024 [Universidad de Guanajuato].

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairments and is considered the most prevalent form of dementia. Among the contributing factors to AD lies the hyperphosphorylation of the microtubule‐associated protein tau. Phosphorylated tau reduces its affinity for microtubules and triggers other posttranslational modifications that result in its aggregation and assembly into filaments. These structures progressively accumulate within neurons leading to neurodegeneration. While current AD medications often involve undesirable side effects, the exploration of natural products as a potential therapeutic alternative has gained considerable attention. Numerous compounds have shown potential capacity for reducing tau pathology through different mechanisms, such as inhibiting kinases to reduce tau hyperphosphorylation, enhancing phosphatase activity, and blocking fibril formation. Since tau hyperphosphorylation‐induced aggregation is pivotal in AD onset, this review aims to elucidate the potential of natural products in modulating this crucial molecular mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer Diseasetau ProteinsBiological ProductsProtein Aggregation, PathologicalHumansPhosphorylationAnimals

Stichwörter der Autor:innen

Alzheimer's diseasedementiaplant extracttau fibrilstau phosphorylation

Substanzen

tau ProteinsBiological Products

Autor:innen und Institutionen

  • División de Ciencias e Ingenierías, Universidad de Guanajuato, León, Guanajuato, Mexico.
  • Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana Cuajimalpa, Ciudad de México, Mexico.

Förderung

  • CONAHCYT
  • Convocatoria Institucional de Investigación Científica 2024 [Universidad de Guanajuato]

Zitieren

APA

Basurto-Islas, G., Diaz, M. C., Ocampo, L. M. Z., Martínez-Herrera, M., & López-Camacho, P. Y. (2025). Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400721

Vancouver

Basurto-Islas G, Diaz MC, Ocampo LMZ, Martínez-Herrera M, López-Camacho PY. Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400721

BibTeX
@article{BasurtoIslas2025,
  author = {Basurto-Islas, Gustavo and Diaz, Maximiliano Caye and Ocampo, Lizeth M Zavala and Martínez-Herrera, Melchor and López-Camacho, Perla Y},
  title = {Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.202400721}
}
Kostenlos starten →